ID   TZAP_HUMAN              Reviewed;         688 AA.
AC   P10074; Q5SY19;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   07-APR-2021, entry version 209.
DE   RecName: Full=Telomere zinc finger-associated protein {ECO:0000303|PubMed:28082411};
DE            Short=TZAP {ECO:0000303|PubMed:28082411};
DE   AltName: Full=Krueppel-related zinc finger protein 3 {ECO:0000303|PubMed:9516840};
DE            Short=hKR3 {ECO:0000303|Ref.12};
DE   AltName: Full=Zinc finger and BTB domain-containing protein 48 {ECO:0000312|HGNC:HGNC:4930};
DE   AltName: Full=Zinc finger protein 855 {ECO:0000312|HGNC:HGNC:4930};
GN   Name=ZBTB48 {ECO:0000312|HGNC:HGNC:4930};
GN   Synonyms=HKR3 {ECO:0000303|PubMed:9516840},
GN   TZAP {ECO:0000303|PubMed:28082411}, ZNF855 {ECO:0000312|HGNC:HGNC:4930};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], DNA-BINDING, AND FUNCTION.
RX   PubMed=7969177; DOI=10.1128/mcb.14.12.8438;
RA   Sugawara M., Scholl T., Ponath P.D., Strominger J.L.;
RT   "A factor that regulates the class II major histocompatibility complex gene
RT   DPA is a member of a subfamily of zinc finger proteins that includes a
RT   Drosophila developmental control protein.";
RL   Mol. Cell. Biol. 14:8438-8450(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=9516840; DOI=10.1016/s0959-8049(97)00279-7;
RA   Maris J.M., Jensen J., Sulman E.P., Beltinger C.P., Allen C., Biegel J.A.,
RA   Brodeur G.M., White P.S.;
RT   "Human Kruppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma
RT   tumour suppressor gene?";
RL   Eur. J. Cancer 33:1991-1996(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 461-488.
RX   PubMed=2850480; DOI=10.1128/mcb.8.8.3104;
RA   Ruppert J.M., Kinzler K.W., Wong A.J., Bigner S.H., Kao F.T., Law M.L.,
RA   Seuanez H.N., O'Brien S.J., Vogelstein B.;
RT   "The GLI-Kruppel family of human genes.";
RL   Mol. Cell. Biol. 8:3104-3113(1988).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH EP300.
RX   PubMed=24382891; DOI=10.1074/jbc.m113.526855;
RA   Yoon J.H., Choi W.I., Jeon B.N., Koh D.I., Kim M.K., Kim M.H., Kim J.,
RA   Hur S.S., Kim K.S., Hur M.W.;
RT   "Human Kruppel-related 3 (HKR3) is a novel transcription activator of
RT   alternate reading frame (ARF) gene.";
RL   J. Biol. Chem. 289:4018-4031(2014).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-169; SER-171 AND SER-179, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF HIS-596.
RX   PubMed=28500257; DOI=10.15252/embr.201744095;
RA   Jahn A., Rane G., Paszkowski-Rogacz M., Sayols S., Bluhm A., Han C.T.,
RA   Draskovic I., Londono-Vallejo J.A., Kumar A.P., Buchholz F., Butter F.,
RA   Kappei D.;
RT   "ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional
RT   activator.";
RL   EMBO Rep. 18:929-946(2017).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-143 AND LYS-263, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DOMAIN.
RX   PubMed=28082411; DOI=10.1126/science.aah6752;
RA   Li J.S., Miralles Fuste J., Simavorian T., Bartocci C., Tsai J.,
RA   Karlseder J., Lazzerini Denchi E.;
RT   "TZAP: A telomere-associated protein involved in telomere length control.";
RL   Science 355:638-641(2017).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.74 ANGSTROMS) OF 2-120.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the human BTB domain of the krueppel-related zinc
RT   finger protein 3 (hKR3).";
RL   Submitted (NOV-2007) to the PDB data bank.
CC   -!- FUNCTION: Telomere-binding protein that acts as a regulator of telomere
CC       length (PubMed:28500257, PubMed:28082411). Directly binds the telomeric
CC       double-stranded 5'-TTAGGG-3' repeat (PubMed:28500257, PubMed:28082411).
CC       Preferentially binds to telomeres that have a low concentration of
CC       shelterin complex and acts as a regulator of telomere length by
CC       initiating telomere trimming, a process that prevents the accumulation
CC       of aberrantly long telomeres (PubMed:28082411). Also acts as a
CC       transcription regulator that binds to promoter regions (PubMed:7969177,
CC       PubMed:24382891, PubMed:28500257). Regulates expression of a small
CC       subset of genes, including MTFP1 (PubMed:28500257). Regulates
CC       expression the J and/or S elements in MHC II promoter (PubMed:7969177).
CC       Acts as a negative regulator of cell proliferation by specifically
CC       activating expression of ARF, a tumor suppressor isoform of CDKN2A
CC       (PubMed:24382891). {ECO:0000269|PubMed:24382891,
CC       ECO:0000269|PubMed:28082411, ECO:0000269|PubMed:28500257,
CC       ECO:0000269|PubMed:7969177}.
CC   -!- SUBUNIT: Interacts with EP300 (PubMed:24382891).
CC       {ECO:0000269|PubMed:24382891}.
CC   -!- INTERACTION:
CC       P10074; Q8NHQ1: CEP70; NbExp=3; IntAct=EBI-744864, EBI-739624;
CC       P10074; Q92997: DVL3; NbExp=4; IntAct=EBI-744864, EBI-739789;
CC       P10074; Q9NWQ4: GPATCH2L; NbExp=3; IntAct=EBI-744864, EBI-5666657;
CC       P10074; Q07627: KRTAP1-1; NbExp=3; IntAct=EBI-744864, EBI-11959885;
CC       P10074; P60370: KRTAP10-5; NbExp=3; IntAct=EBI-744864, EBI-10172150;
CC       P10074; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-744864, EBI-10172290;
CC       P10074; Q969R5: L3MBTL2; NbExp=3; IntAct=EBI-744864, EBI-739909;
CC       P10074; P02545: LMNA; NbExp=3; IntAct=EBI-744864, EBI-351935;
CC       P10074; P23508: MCC; NbExp=3; IntAct=EBI-744864, EBI-307531;
CC       P10074; Q9Y5B8: NME7; NbExp=6; IntAct=EBI-744864, EBI-744782;
CC       P10074; Q96CV9: OPTN; NbExp=3; IntAct=EBI-744864, EBI-748974;
CC       P10074; Q5MJ10: SPANXN2; NbExp=3; IntAct=EBI-744864, EBI-12023934;
CC       P10074; Q9NVV9: THAP1; NbExp=3; IntAct=EBI-744864, EBI-741515;
CC       P10074; Q8WV44: TRIM41; NbExp=4; IntAct=EBI-744864, EBI-725997;
CC       P10074; Q9H2G4: TSPYL2; NbExp=3; IntAct=EBI-744864, EBI-947459;
CC       P10074; P61964: WDR5; NbExp=3; IntAct=EBI-744864, EBI-540834;
CC       P10074; Q9HCK0: ZBTB26; NbExp=3; IntAct=EBI-744864, EBI-3918996;
CC       P10074; P10074: ZBTB48; NbExp=4; IntAct=EBI-744864, EBI-744864;
CC       P10074; Q15916: ZBTB6; NbExp=3; IntAct=EBI-744864, EBI-7227791;
CC       P10074; Q96BR9: ZBTB8A; NbExp=7; IntAct=EBI-744864, EBI-742740;
CC       P10074; Q96C00: ZBTB9; NbExp=3; IntAct=EBI-744864, EBI-395708;
CC       P10074; Q96PQ6: ZNF317; NbExp=3; IntAct=EBI-744864, EBI-1210473;
CC       P10074; Q9H9D4: ZNF408; NbExp=3; IntAct=EBI-744864, EBI-347633;
CC       P10074; Q96EG3: ZNF837; NbExp=3; IntAct=EBI-744864, EBI-11962574;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Chromosome, telomere
CC       {ECO:0000269|PubMed:28082411, ECO:0000269|PubMed:28500257}.
CC       Note=Directly binds the telomeric double-stranded 5'-TTAGGG-3' repeat
CC       (PubMed:28500257, PubMed:28082411). According to a report,
CC       preferentially binds to long telomeres that have a low concentration of
CC       shelterin complex, competing with the telomeric repeat binding factors
CC       TERF1 and TERF2 (PubMed:28082411). According to another report, binds
CC       telomeres regardless of their length (PubMed:28500257).
CC       {ECO:0000269|PubMed:28082411, ECO:0000269|PubMed:28500257}.
CC   -!- TISSUE SPECIFICITY: Detected in adrenal gland and neuroblastoma.
CC       {ECO:0000269|PubMed:9516840}.
CC   -!- DOMAIN: The C2H2-type zinc fingers mediate binding to the telomeric
CC       double-stranded 5'-TTAGGG-3' repeats (PubMed:28082411). The last C2H2-
CC       type zinc finger is required for telomeric-binding (PubMed:28500257).
CC       {ECO:0000269|PubMed:28082411, ECO:0000269|PubMed:28500257}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- CAUTION: According to a study, preferentially binds to long telomeres
CC       that have a low concentration of shelterin complex (PubMed:28082411).
CC       According to another report, binds telomeres regardless of their length
CC       (PubMed:28500257). {ECO:0000269|PubMed:28082411,
CC       ECO:0000269|PubMed:28500257}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L16896; AAA65124.1; -; mRNA.
DR   EMBL; U45325; AAB08973.1; -; Genomic_DNA.
DR   EMBL; U45324; AAB08973.1; JOINED; Genomic_DNA.
DR   EMBL; AL591866; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC013573; AAH13573.1; -; mRNA.
DR   EMBL; M20677; AAA35989.1; -; Genomic_DNA.
DR   CCDS; CCDS84.1; -.
DR   PIR; A56360; A56360.
DR   RefSeq; NP_001265576.1; NM_001278647.1.
DR   RefSeq; NP_001265577.1; NM_001278648.1.
DR   RefSeq; NP_005332.1; NM_005341.3.
DR   PDB; 3B84; X-ray; 1.74 A; A=4-120.
DR   PDB; 5YJ3; X-ray; 2.85 A; C/D=516-620.
DR   PDBsum; 3B84; -.
DR   PDBsum; 5YJ3; -.
DR   SMR; P10074; -.
DR   BioGRID; 109349; 128.
DR   IntAct; P10074; 101.
DR   MINT; P10074; -.
DR   STRING; 9606.ENSP00000366902; -.
DR   iPTMnet; P10074; -.
DR   PhosphoSitePlus; P10074; -.
DR   BioMuta; ZBTB48; -.
DR   DMDM; 1708212; -.
DR   EPD; P10074; -.
DR   jPOST; P10074; -.
DR   MassIVE; P10074; -.
DR   MaxQB; P10074; -.
DR   PaxDb; P10074; -.
DR   PeptideAtlas; P10074; -.
DR   PRIDE; P10074; -.
DR   ProteomicsDB; 52561; -.
DR   Antibodypedia; 13109; 144 antibodies.
DR   DNASU; 3104; -.
DR   Ensembl; ENST00000377674; ENSP00000366902; ENSG00000204859.
DR   GeneID; 3104; -.
DR   KEGG; hsa:3104; -.
DR   UCSC; uc001anx.5; human.
DR   CTD; 3104; -.
DR   DisGeNET; 3104; -.
DR   GeneCards; ZBTB48; -.
DR   HGNC; HGNC:4930; ZBTB48.
DR   HPA; ENSG00000204859; Low tissue specificity.
DR   MIM; 165270; gene.
DR   neXtProt; NX_P10074; -.
DR   OpenTargets; ENSG00000204859; -.
DR   PharmGKB; PA162409481; -.
DR   VEuPathDB; HostDB:ENSG00000204859.11; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000158981; -.
DR   HOGENOM; CLU_002678_70_0_1; -.
DR   InParanoid; P10074; -.
DR   OMA; RERGQYC; -.
DR   OrthoDB; 1318335at2759; -.
DR   PhylomeDB; P10074; -.
DR   TreeFam; TF331310; -.
DR   PathwayCommons; P10074; -.
DR   BioGRID-ORCS; 3104; 11 hits in 1017 CRISPR screens.
DR   ChiTaRS; ZBTB48; human.
DR   EvolutionaryTrace; P10074; -.
DR   GenomeRNAi; 3104; -.
DR   Pharos; P10074; Tbio.
DR   PRO; PR:P10074; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P10074; protein.
DR   Bgee; ENSG00000204859; Expressed in testis and 184 other tissues.
DR   ExpressionAtlas; P10074; baseline and differential.
DR   Genevisible; P10074; HS.
DR   GO; GO:0000781; C:chromosome, telomeric region; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0003691; F:double-stranded telomeric DNA binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0010833; P:telomere maintenance via telomere lengthening; IMP:UniProtKB.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   Pfam; PF00096; zf-C2H2; 6.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 11.
DR   SUPFAM; SSF54695; SSF54695; 1.
DR   SUPFAM; SSF57667; SSF57667; 6.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 9.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 11.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Chromosome; DNA-binding; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Telomere; Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..688
FT                   /note="Telomere zinc finger-associated protein"
FT                   /id="PRO_0000047272"
FT   DOMAIN          26..89
FT                   /note="BTB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00037"
FT   ZN_FING         291..313
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         319..341
FT                   /note="C2H2-type 2; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         350..372
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         378..401
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         407..430
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         436..459
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         465..487
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         493..515
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         521..544
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         550..572
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         578..600
FT                   /note="C2H2-type 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   MOD_RES         169
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         171
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         179
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   CROSSLNK        143
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        263
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VARIANT         675
FT                   /note="S -> A (in dbSNP:rs2229330)"
FT                   /id="VAR_052925"
FT   MUTAGEN         596
FT                   /note="H->A: Abolishes binding to the telomeric double-
FT                   stranded 5'-TTAGGG-3' repeat."
FT                   /evidence="ECO:0000269|PubMed:28500257"
FT   CONFLICT        201
FT                   /note="P -> S (in Ref. 1; AAA65124)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        244
FT                   /note="D -> S (in Ref. 1; AAA65124)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        350..351
FT                   /note="FT -> LP (in Ref. 1; AAA65124)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        607
FT                   /note="N -> K (in Ref. 1; AAA65124)"
FT                   /evidence="ECO:0000305"
FT   HELIX           5..22
FT                   /evidence="ECO:0007744|PDB:3B84"
FT   STRAND          28..32
FT                   /evidence="ECO:0007744|PDB:3B84"
FT   STRAND          35..39
FT                   /evidence="ECO:0007744|PDB:3B84"
FT   HELIX           41..47
FT                   /evidence="ECO:0007744|PDB:3B84"
FT   HELIX           49..55
FT                   /evidence="ECO:0007744|PDB:3B84"
FT   TURN            56..59
FT                   /evidence="ECO:0007744|PDB:3B84"
FT   STRAND          63..65
FT                   /evidence="ECO:0007744|PDB:3B84"
FT   HELIX           67..69
FT                   /evidence="ECO:0007744|PDB:3B84"
FT   HELIX           70..82
FT                   /evidence="ECO:0007744|PDB:3B84"
FT   TURN            89..91
FT                   /evidence="ECO:0007744|PDB:3B84"
FT   HELIX           92..101
FT                   /evidence="ECO:0007744|PDB:3B84"
FT   HELIX           105..113
FT                   /evidence="ECO:0007744|PDB:3B84"
FT   STRAND          553..555
FT                   /evidence="ECO:0007744|PDB:5YJ3"
FT   STRAND          558..562
FT                   /evidence="ECO:0007744|PDB:5YJ3"
FT   HELIX           563..570
FT                   /evidence="ECO:0007744|PDB:5YJ3"
FT   TURN            581..583
FT                   /evidence="ECO:0007744|PDB:5YJ3"
FT   STRAND          586..589
FT                   /evidence="ECO:0007744|PDB:5YJ3"
FT   HELIX           590..600
FT                   /evidence="ECO:0007744|PDB:5YJ3"
SQ   SEQUENCE   688 AA;  77054 MW;  EBECCE3D6CBBD524 CRC64;
     MDGSFVQHSV RVLQELNKQR EKGQYCDATL DVGGLVFKAH WSVLACCSHF FQSLYGDGSG
     GSVVLPAGFA EIFGLLLDFF YTGHLALTSG NRDQVLLAAR ELRVPEAVEL CQSFKPKTSV
     GQAAGGQSGL GPPASQNVNS HVKEPAGLEE EEVSRTLGLV PRDQEPRGSH SPQRPQLHSP
     AQSEGPSSLC GKLKQALKPC PLEDKKPEDC KVPPRPLEAE GAQLQGGSNE WEVVVQVEDD
     GDGDYMSEPE AVLTRRKSNV IRKPCAAEPA LSAGSLAAEP AENRKGTAVP VECPTCHKKF
     LSKYYLKVHN RKHTGEKPFE CPKCGKCYFR KENLLEHEAR NCMNRSEQVF TCSVCQETFR
     RRMELRVHMV SHTGEMPYKC SSCSQQFMQK KDLQSHMIKL HGAPKPHACP TCAKCFLSRT
     ELQLHEAFKH RGEKLFVCEE CGHRASSRNG LQMHIKAKHR NERPHVCEFC SHAFTQKANL
     NMHLRTHTGE KPFQCHLCGK TFRTQASLDK HNRTHTGERP FSCEFCEQRF TEKGPLLRHV
     ASRHQEGRPH FCQICGKTFK AVEQLRVHVR RHKGVRKFEC TECGYKFTRQ AHLRRHMEIH
     DRVENYNPRQ RKLRNLIIED EKMVVVALQP PAELEVGSAE VIVESLAQGG LASQLPGQRL
     CAEESFTGPG VLEPSLIITA AVPEDCDT
//
